Ascendis Pharma AS Earnings

The next earnings date for Ascendis Pharma AS is November 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Ascendis Pharma AS Earnings

Report Date	Estimated Earnings Per Share
11/06/2025	$-0.28

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Ascendis Pharma AS Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/07/2025	---	$0	100.00%
04/30/2025	Before Market	$-1.58	-4.95%
02/13/2025	---	$-0.64	31.38%
11/05/2024	After Market	$-1.72	8.99%
09/03/2024	After Market	$-2.11	-44.52%
05/02/2024	After Market	$-2.30	-53.33%
02/07/2024	After Market	$-1.54	24.14%
11/07/2023	After Market	$-2.88	-21.01%
09/05/2023	After Market	$-2.16	16.60%
04/27/2023	After Market	$-1.98	25.56%
02/16/2023	After Market	$-3.70	-44.53%
11/02/2022	After Market	$-3.03	-21.69%
08/10/2022	After Market	$-1.46	31.46%
05/11/2022	After Market	$-2.21	-10.50%
03/02/2022	After Market	$-1.87	20.09%
11/10/2021	After Market	$-1.47	35.81%
08/25/2021	After Market	$-2.50	-12.11%
05/27/2021	After Market	$-1.17	31.58%
03/10/2021	After Market	$-2.64	-70.32%
11/11/2020	After Market	$-2.31	-46.20%
08/27/2020	After Market	$-1.97	-36.81%
05/19/2020	After Market	$-1.32	2.22%
11/18/2019	After Market	$-0.53	55.46%
08/28/2019	After Market	$-1.25	-3.31%
05/30/2019	After Market	$-1.24	-24.00%
12/31/2018	---	$-0.86	24.56%
11/28/2018	After Market	$-0.81	24.30%
08/29/2018	After Market	$-0.55	38.89%
05/30/2018	After Market	$-1.07	-38.96%
03/28/2018	After Market	$-0.92	-15.00%
11/16/2017	After Market	$-1.04	-40.54%
08/18/2017	Before Market	$-0.94	-30.56%
05/23/2017	After Market	$-0.83	-10.67%
03/22/2017	After Market	$-0.67	-8.06%
11/30/2016	After Market	$-0.80	-17.65%
08/31/2016	After Market	$-0.60	13.04%
04/14/2016	After Market	$-0.54	-17.39%
11/12/2015	Before Market	$-0.33	45.00%
08/24/2015	After Market	$-0.70	-42.86%
05/18/2015	After Market	$0.07	117.95%
03/25/2015	After Market	$-0.65	---

More About Ascendis Pharma AS

Website

https://ascendispharma.com

Country

USA

Full Time Employees

1,017

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

“Ascendis Pharma AS Earnings” Can Refer to the Ascendis Pharma AS Earnings Date

Some people say “Ascendis Pharma AS earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Ascendis Pharma AS position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Ascendis Pharma AS Stock on the Earnings Date

If you own Ascendis Pharma AS stock (ASND) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Ascendis Pharma AS might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Ascendis Pharma AS shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Ascendis Pharma AS Earnings

You can contact us any time if you would like to ask questions about Ascendis Pharma AS earnings or anything else related to the stock market.